US equity prices have sharply dropped from all-time highs notched in mid-February, reflecting a significant shift in investor ...

Ohio native Bill Lowen won the 2025 FXR Pro Fish Bassmaster Elite at Florida's St. Johns River with a total weight of 73 pounds, 14 ounces.

As the Federal Reserve recalibrates rate cut expectations for 2025, short-term Treasuries remain attractive, while bond ...

Best Anime Movies Of All Time Best Anime Movies Best Anthology Movies Best Anime Short Films Best Anime TV Shows Of All Time Best Anime TV Shows Of All Time Best Anime Series Best Anime OVAs Best ...

When Beyoncé announced she was pregnant with first child Blue Ivy Carter at the MTV Video Music Awards, her fans were ecstatic. The singer was three years into her marriage to Jay-Z and touched ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...

The background color is inspired by International Klein Blue, a hue that the artist Yves Klein first mixed in the 1950s, using it to make an array of monochromatic paintings until his death in 1962.

“We are excited to deliver FXR314 and our FXR program to Lilly for Phase 2 and further development. Their world-class development excellence and dedication to delivering for patients will provide an ...

Organovo Holdings, Inc. announced that it will be acquired by Eli Lilly and Company, which includes Organovo's FXR program and its lead asset, FXR314, aimed at treating inflammatory bowel disease ...

Eli Lil­ly is buy­ing Organo­vo’s far­ne­soid X re­cep­tor (FXR) ag­o­nist pro­gram, which in­cludes a drug in Phase 2 de­vel­op­ment for ul­cer­a­tive col­i­tis and meta­bol ...

Organovo shares are trading higher by 246% Tuesday morning. The company announced that Eli Lilly is set to acquire its FXR program, including FXR314. Find out which stock just claimed the top spot ...

SAN DIEGO - Organovo Holdings, Inc. (NASDAQ:ONVO), a biotech firm specializing in 3D human tissue models, has reached an agreement to sell its FXR program, including the lead asset FXR314 ...